Literature DB >> 25293592

Occurrence of soluble supra-molecular FN-fibrin complexes in the plasma of children with recurrent respiratory infection.

Anna Lemańska-Perek1, Bożena Polańska2, Dorota Krzyżanowska-Gołąb3, Iwona Kątnik-Prastowska3.   

Abstract

OBJECTIVES: Fibronectin (FN) is able to bind fibrin and FN-fibrin complexes and is found in the plasma of some patients suffering from inflammatory disease. The present study was undertaken to determine whether soluble supra-molecular FN-fibrin complexes were present in the plasma of children with recurrent respiratory infections (RRI). DESIGN AND METHODS: The frequency of occurrence and relative amounts of the supra-molecular FN-fibrin forms, concentrations of immunoglobulins and numbers of natural killer cells (NK) were determined in the plasma of children with recurrent respiratory infections. The frequencies of these parameters were compared with their frequencies in the plasma of children with acute respiratory infections and plasma from healthy children.
RESULTS: SDS-agarose immunoblotting of patients' plasma revealed the presence of several additional FN-fibrin bands, with decreasing electrophoretic mobilities and increasing molecular masses of 750 kDa, 1000 kDa, 1300 kDa, 1600 kDa and 1900 kDa. Such FN-fibrin complexes occurred with higher frequency and in larger amounts in the plasma of children with RRI and acute infection than they did in plasma from normal children. Moreover, bands above 1000 kDa were absent in most young healthy individuals. The occurrence of FN-fibrin complexes did not correlate with either immunoglobulin concentrations, or with the number of NK cells.
CONCLUSIONS: The occurrence of plasma supra-molecular FN-fibrin complexes is associated with acute and recurrent respiratory infections of children.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  FN–fibrin complexes; Fibronectin; NK cells; immunoblotting; recurrent respiratory infection

Mesh:

Substances:

Year:  2014        PMID: 25293592     DOI: 10.1177/0004563214556650

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  6 in total

1.  Time-dependent changes in extra-domain A-fibronectin concentration and relative amounts of fibronectin-fibrin complexes in plasma of patients with peripheral arterial disease after endovascular revascularisation.

Authors:  Małgorzata Pupek; Dorota Krzyżanowska-Gołąb; Daniel Kotschy; Wojciech Witkiewicz; Wiesława Kwiatkowska; Maria Kotschy; Iwona Kątnik-Prastowska
Journal:  Int Wound J       Date:  2018-03-13       Impact factor: 3.315

2.  Fibronectin as a Marker of Disease Severity in Critically Ill COVID-19 Patients.

Authors:  Anna Lemańska-Perek; Dorota Krzyżanowska-Gołąb; Barbara Dragan; Maciej Tyszko; Barbara Adamik
Journal:  Cells       Date:  2022-05-06       Impact factor: 7.666

3.  Changes of plasma fibronectin and fibronectin-fibrin complexes in dams of stillborn dairy calves.

Authors:  Paulina Jawor; Dorota Krzyżanowska-Gołąb; Joanna Bajzert; Tadeusz Stefaniak; Iwona Kątnik-Prastowska
Journal:  Ir Vet J       Date:  2020-08-09       Impact factor: 2.146

4.  Fibronectin Molecular Status in Plasma of Women with Endometriosis and Fertility Disorders.

Authors:  Jolanta Lis-Kuberka; Paulina Kubik; Agnieszka Chrobak; Jarosław Pająk; Anna Chełmońska-Soyta; Magdalena Orczyk-Pawiłowicz
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

5.  Analysis of Soluble Molecular Fibronectin-Fibrin Complexes and EDA-Fibronectin Concentration in Plasma of Patients with Atherosclerosis.

Authors:  Anna Lemańska-Perek; Dorota Krzyżanowska-Gołąb; Małgorzata Pupek; Piotr Klimeczek; Wojciech Witkiewicz; Iwona Kątnik-Prastowska
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

6.  Data Mining and Systematic Pharmacology to Reveal the Mechanisms of Traditional Chinese Medicine in Recurrent Respiratory Tract Infections' Treatment.

Authors:  Changyong Luo; He Yu; Tao Yang; Chen Bai; Bing He; Yurou Yan; Tiegang Liu; Junhong Wang; Xiaohong Gu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-26       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.